Signal transducers and activators of transcription (STAT) proteins are transcription factors activated by phosphorylation on tyrosine residues after cytokine stimulation. In erythropoietin receptor (EPOR)-mediated signaling, STAT5 is tyrosine-phosphorylated by EPO stimulation. Although Janus Kinase 2 (JAK2) is reported to play a crucial role in EPO-induced activation of STAT5, it is unclear whether JAK2 alone can tyrosinephosphorylate STAT5 after EPO stimulation. Several studies indicate that STAT activation is caused by members of other families of protein tyrosine kinases such as the Src family. We previously reported that reduction of Src by induction of antisense src RNA expression suppressed EPO-promoted erythroid dierentiation in K562 cells. In the present study, we explored the function of Src downstream of the EPOR-initiated signaling. Reduction of Src diminished tyrosine phosphorylation of STAT5 in K562 cells regardless of EPO treatment. The tyrosine phosphorylation level of STAT5 induced by EPO in F-36P cells was reduced in the presence of PP1 or PP2 selective Src inhibitor. In addition, the expression of dominant negative Src in F-36P cells reduced the tyrosine phosphorylation of STAT5. When Src and STAT5 were co-expressed in COS7 cells, tyrosine phosphorylation of STAT5 was observed, and tyrosine residue 694 (Tyr 694) of STAT5A was identi®ed as the major phosphorylation site by Src. In vitro kinase assay revealed that GST-STAT5 fusion protein with the conserved C-terminal, but not the Cterminal-truncated mutant which lacks Tyr 694, was tyrosine-phosphorylated by Src. Src can thus directly tyrosine-phosphorylate the activation site of STAT5 (Tyr 694 in STAT5A), and Src may contribute to EPOinduced signal transduction via STAT5. Oncogene (2001) 20, 6643 ± 6650.
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Keywords: Src; STAT5; erythropoietin; tyrosine phosphorylation; antisense Growth and dierentiation of hematopoietic cells are regulated by the interaction of cell surface receptors with their speci®c cytokines or growth factors. While some of these receptors transmit signals via their intrinsic protein tyrosine kinase (PTK) activity, others use cytoplasmic non-receptor PTK for mediating signals (van der Geer et al., 1994) . The binding of erythropoietin (EPO) to an erythropoietin receptor (EPOR) which does not contain any intrinsic PTK activity induces rapid and transient tyrosine phosphorylation of intracellular proteins (Constantinescu et al., 1999) .
Signal transducers and activators of transcription (STAT) proteins are transcription factors that play key roles in intracellular signaling after stimulation with various cytokines and growth factors (Darnell et al., 1994; O'Shea, 1997; Coer et al., 2000) . Among the seven members of the STAT family, STAT5 is known to be activated by a wide variety of cytokines, including EPO O'Shea, 1997) . Two closely related STAT5 proteins, STAT5A and STAT5B, have been identi®ed with 96% homology at the amino acid sequence level (Liu et al., 1995; . Although a previous study showed that hematopoietic development in the myeloid and erythroid lineages was not signi®cantly impaired in adult mice de®cient in both STAT5A and STAT5B genes (Teglund et al., 1998) , analyses of these mice during fetal development and experiments using cell lines have suggested that STAT5 plays important roles in the proliferation and dierentiation of hematopoietic cells, including erythroid progenitors (Iwatsuki et al., 1997; Nosaka et al., 1999; Socolovsky et al., 1999) .
One or more members of Janus Kinase (JAK) family PTKs have been reported to be activated by a wide range of cytokines (Ihle, 1995) . Although JAK2 has been reported to play an important role in the EPOinduced signal transduction which activates STAT5 (Ihle, 1995; Coer et al., 2000) , it is still an open question whether JAK2 is the only PTK responsible for the tyrosine phosphorylation of STAT5 after stimulation with EPO. Several reports have recently suggested that other families of PTKs are involved in STAT activation. Overexpression of v-Src or v-Abl has been shown to activate various STAT proteins (Danial et al., 1995; Yu et al., 1995; Cao et al., 1996) . In a K562 erythroleukemia cell line derived from a patient with CML in blastic crisis, STAT5 was shown to be constitutively activated and to play a crucial role in cellular transformation by the bcr-abl oncogene (Carlesso et al., 1996; de Groot et al., 1999) . Furthermore, it was reported that STATs were activated by Src PTK after stimulation with interleukin-3 or epidermal growth factor (Chaturvedi et al., 1998; Olayioye et al., 1999) .
Src, a prototype molecule of Src family PTKs, is expressed in a variety of hematopoietic cells (Kitanaka et al., 1994; Thomas and Brugge, 1997) . We previously showed that reduction of Src induced by the antisense src RNA expression suppressed EPO-induced hemoglobin synthesis and glycophorin A expression in K562 cells (Kitanaka et al., 1994) . The mechanism by which Src contributes to the EPOR-mediated signaling cascade has not yet been clari®ed. In the present study, we investigated whether Src is one of the components of a signaling cascade that leads to tyrosine phosphorylation of STAT5 in response to stimulation with EPO.
The amount of Src in K562-ASRC cells (see the legend to Figure 1 ) can be eciently suppressed by treatment with dexamethasone (Dexa) (Figure 1a ), as reported previously (Kitanaka et al., 1994) . The signaling mechanism downstream of Src in K562-ASRC cells after EPO stimulation was investigated by examining its possible role in tyrosine phosphorylation of STAT5. K562-ASRC cells were stimulated with EPO with or without Dexa treatment. Although constitutive tyrosine phosphorylation of STAT5 has been observed in K562 cells (Carlesso et al., 1996; de Groot et al., 1999) , incubation of the cells in serum-free medium for 24 h reduced the baseline level of STAT5 tyrosine phosphorylation (data not shown). Under these experimental conditions, we could detect an increase in the tyrosine phosphorylation of STAT5 in response to EPO treatment ( Figure 1b ). Downregulation of Src diminished the increase in the tyrosine phosphorylation of STAT5 caused by EPO stimulation (Figure 1b) . Figure 1 Induction of antisense src RNA expression suppresses tyrosine phosphorylation of STAT5 induced by EPO. Establishment of K562 cells transfected with an antisense src RNA expression vector in which antisense src RNA expression is promoted by Dexa (K562-ASRC cells) was previously described (Kitanaka et al., 1994) . (a) K562-ASRC cells were incubated with or without 2 mM of Dexa for 24 h. Cell lysates were prepared as described previously (Kitanaka et al., 1998) . Cell lysates containing equal amounts of proteins were subjected to immunoprecipitation with a monoclonal anti-Src antibody (Oncogene Science).
Immunoprecipitated proteins were separated by 7.5% SDS ± PAGE and transferred to a PVDF ®lter. The ®lter was incubated with the anti-Src antibody. The antibody binding was visualized by means of an enhanced chemiluminescence detection system (Amersham). The positions of Src, immunoglobulin heavy chain (IgH) and molecular mass markers (in kD) are indicated. (b) Serum-starved K562-ASRC cells were incubated with Dexa for 24 h. The cells were then incubated for 5 min in the presence or absence of 30 U/ml recombinant human EPO (Kirin Brewery) and lysed in the lysis buer. The cell lysates were subjected to immunoprecipitation with a monoclonal anti-STAT5 antibody (Santa Cruz), followed by Western blotting using an antiphosphotyrosine antibody (a-pTyr, upper panel; Santa Cruz). The ®lter was stripped and reprobed with the anti-STAT5 antibody (lower panel)
To further investigate the role of Src in EPO-induced tyrosine phosphorylation of STAT5, we took advantage of three compounds, the Src PTK inhibitors PP1 and PP2 and the JAK PTK inhibitor AG490. PP1 and PP2 preferentially inhibit Src family PTKs without inhibiting JAK family PTKs, while AG 490 selectively inhibits JAKs (Hanke et al., 1996; Meydan et al., 1996 ; Figure 2 and data not shown). We ®rst examined whether inhibition of Src PTK activity aects the EPOinduced tyrosine phosphorylation of STAT5 in the human erythroleukemia cell line F-36P, which can be induced to dierentiate into the erythroid lineage in response to EPO (Chiba et al., 1991) . As shown in Figure 2a , both PP1 and PP2 dose-dependently reduced the tyrosine phosphorylation of STAT5 as compared with that induced by EPO without inhibitors, whereas PP3, an inactive analog, had no eect. In contrast, both PP1 and PP2 had little eect on the tyrosine phosphorylation of JAK2. These results suggest that Src PTK activity is required for EPOinduced tyrosine phosphorylation of STAT5 and that the PTK activity of JAK2 enhanced by its tyrosine phosphorylation is not adequate for maximal phosphorylation of STAT5. We then examined whether inhibition of JAK PTKs by AG490 aects the extent of tyrosine phosphorylation of STAT5 in F-36P cells. Although the enhancement of JAK2 tyrosine phosphorylation was completely inhibited by treatment with 100 mM of AG490, an EPO-promoted increase in STAT5 tyrosine phosphorylation was still detectable (Figure 2b ), suggesting that this phosphorylation was induced independently of JAK2. Neither Src PTK inhibitors nor the JAK PTK inhibitor completely blocked the tyrosine phosphorylation of STAT5. Thus, Src and JAK2 cooperatively tyrosine-phosphorylate STAT5.
To corroborate the results obtained using PTK inhibitors, we established stable transfectants of F-36P cells expressing a dominant negative Src (Src-DN) with mutations of Lys 296 to Arg and Tyr 528 to Phe (Mukhopadhyay et al., 1995) . In the selected transfectant clones, the amounts of Src were much greater than in mock-transfected F-36P cells because of the high expression levels of Src-DN (Figure 3a) . In F-36P cells expressing Src-DN, the extent of EPO-induced tyrosine phosphorylation of STAT5 was signi®cantly impaired (Figure 3b ). In contrast, the tyrosine phosphorylation of JAK2 in these cells was similar to that observed in mock-transfected cells. These results indicate that Src, In order to investigate the ability of Src to tyrosinephosphorylate STAT5, Src and STAT5A or STAT5B were transiently expressed in COS7 cells. Co-expression of kinase active Src, but not kinase-inactive Src, markedly enhanced the extent of tyrosine phosphorylation of both STAT5A and STAT5B (Figure 4a) . Several reports have shown the complex formation between Src and STAT proteins including STAT5 (Cao et al., 1996; Chaturvedi et al., 1998; Kazansky et al., 1999) . However, we have not been successful to date in co-immunoprecipitating considerable amounts of STAT5 with Src from the plasmids-transfected COS7 cells (data not shown). Of note, from JAK2-cotransfected COS7 cells in which Src and STAT5 were co-expressed, the amount of STAT5 co-immunoprecipitated with Src was increased to such an extent that it was detected by Western blotting, suggesting that JAK2 plays a role in their assembly and/or stabilization of the Src-STAT5 complex (data not shown). It is interesting to note that others have also failed to detect co-immunoprecipitation of v-Src with STAT5 from vsrc-transformed 32Dcl3 cells in which STAT5 was a b Figure 3 Expression of dominant negative Src reduces EPO-induced tyrosine phosphorylation of STAT5. Either the expression vectors for dominant negative Src (UBI) or the empty vectors without insert were electroporated into F-36P cells as described previously (Kitanaka et al., 1999) . ( tyrosine-phosphorylated and activated (Chaturvedi et al., 1997) . These discrepancies in detection of the complex formation between Src and STAT5 may be due to their weak association or dierences in cell lysis conditions in dierent experiments. The tyrosine residue at position 694 (Tyr 694) in the STAT5A amino acid sequence is known to be the site phosphorylated by JAK2 and the regulator of the DNA binding activity of STAT5A (Gouilleux et al., 1994) . Thus, we constructed FLAG-tagged protein expression plasmids for wild-type STAT5A and carboxyl-truncated mutants of STAT5A with or without Tyr 694 (Figure 4b ). The tyrosine phosphorylation levels of full-length and carboxyl-truncated STAT5A mutants in COS7 cells were compared in the presence of co-transfected Src. As illustrated in Figure 4c , (GST-STAT5A-693) of human STAT5A were constructed. To prepare GST-STAT5A-WT, the fragment of human STAT5A cDNA coding an amino acid sequence from 494 to 794 was subcloned into pGEX-6P-2 vector (Pharmacia). C-terminal-deleted GST-STAT5A fusion protein, which is truncated at amino acid 693 (GST-STAT5A-693), was constructed by mutagenesis PCR. GSTfusion proteins in the bacteria were solubilized by being boiled in SDS ± PAGE sample buer, separated by SDS ± PAGE and electroeluted using a Whole Gel Eluter (Bio-Rad). Protein ± protein interaction between GST ± fusion proteins and endogenous proteins in the bacteria was not expected to survive under this denaturing condition. (b) GST-STAT5A-WT or GST-STAT5A-693 was incubated with or without 3 U of anity puri®ed recombinant human Src expressed in Sf9 insect cells (UBI) in a kinase buer containing 10 mM ATP at 258C for 5 min. After the reaction was stopped, samples were subjected to Western blot analysis using the anti-phosphotyrosine antibody (upper panel) followed by reprobing with an anti-GST antibody (lower panel; Santa Cruz). (c) COS7 cells transiently transfected with STAT5A were lysed and immunoprecipitated with the anti-STAT5A antibody. Kinase reactions were performed as in (b) using anti-STAT5A immunoprecipitates as substrates. Samples were subjected to Western blot analysis using the anti-phosphotyrosine antibody (upper panel), polyclonal anti-phospho-STAT5A/B antibody (a-pSTAT5; middle panel; UBI), or anti-STAT5 antibody (bottom panel)
FLAG-tagged wild-type STAT5A co-expressed with Src exhibited a high level of tyrosine phosphorylation. Src-induced tyrosine phosphorylation of STAT5A carboxyl-truncated at Ala 713 (STAT5A-713) was also readily detected. In contrast, carboxyl-truncation at Gly 693 of STAT5A (STAT5A-693), from which Tyr 694 was deleted, diminished the tyrosine phosphorylation of STAT5A. This suggests that Tyr 694 at the carboxyl-terminus of STAT5A is a main phosphorylation site induced by Src. It may be possible to speculate that Src activates endogenous PTK(s) in COS7 cells, which in turn tyrosine-phosphorylate(s) STAT5. To rule out this possibility and to elucidate the kinase-substrate status in Src-mediated STAT5 phosphorylation, we performed in vitro kinase assays. We prepared recombinant GST-fusion proteins which were intact (GST-STAT5A-WT) and carboxyl-truncated STAT5A (GST-STAT5A-693) (Figure 5a ). GST-fusion proteins were incubated in the presence of ATP with or without recombinant Src. Western blot analysis using the antiphosphotyrosine antibody showed marked tyrosine phosphorylation of GST-STAT5A-WT (Figure 5b , left upper panel). In contrast, no tyrosine phosphorylation was observed in GST-STAT5A-693 after kinase reaction with Src ( Figure 5b , right upper panel). Srcmediated tyrosine phosphorylation of STAT5A obtained from STAT5A-transfected COS7 cells was also detected by Western blotting using either the antiphosphotyrosine antibody (Figure 5c, top panel) or an anti-phospho-STAT5A/B (Y694/Y699) antibody (Figure 5c, middle panel) . Similar results were observed in the kinase assay in which anti-STAT5B immunoprecipitates were used as substrates (data not shown). These results are consistent with those of the in vivo phosphorylation on Tyr 694 of STAT5A by Src shown in Figure 4 and strongly support the direct kinasesubstrate relationship between Src and STAT5.
Several investigators have demonstrated the involvement of Lyn, a member of the Src family PTKs widely expressed in hematopoietic cells, in EPO-induced signal transduction (Tilbrook et al., 1997; Chin et al., 1998) . The ability of J2E cells to dierentiate in response to EPO was severely suppressed by treatment with antisense lyn oligonucleotides or expression of dominant negative Lyn. However, the importance of Lyn to other erythroid cell lines and normal erythroid progenitor cells has not yet been clari®ed. Our ongoing study revealed that antisense oligonucleotides against src but not lyn inhibited EPO-induced erythroid dierentiation of K562 cells and EPO-induced development of erythroid colony formation of the cells derived from normal human bone marrow (Y Kubota et al., submitted). These ®ndings indicate that Src may play a more universal role in EPO-induced erythroid dierentiation than Lyn.
Recently, Src-induced tyrosine phosphorylation and DNA binding of STAT5 have been reported (Kazansky et al., 1999) . In this study, Src was shown to associate with STAT5. However, the researchers failed to detect an increase in tyrosine phosphorylation of STAT5 by in vitro kinase assay using the immunoprecipitated Src-STAT5 complex. Although we have not yet succeeded in detecting the tight complex formation between Src and STAT5, a direct kinase-substrate relationship between them was clearly demonstrated by the in vitro kinase assay using GST-STAT5A fusion proteins and recombinant Src under a condition free of mammalian cellular proteins.
In conclusion, our results reveal that STAT5 is a direct target of Src. This implies the existence of Srcmediated STAT5-activating machinery downstream of EPOR. This conclusion is in good agreement with the recently proposed JAK-Src-STAT model which suggests the involvement of Src family PTKs in the cytokine-mediated signaling pathways (Reddy et al., 2000) . Additional studies undertaken in order to determine the role of Src in the STAT5 activation and the contribution of JAK PTK(s) may provide insight into the function of this pathway in EPORmediated signal transduction.
